Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 223

Sort by

Sort Order Select

Journal Articles

Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant

Andrew Lin, Samantha Brown, Stephanie Chinapen, Yeon Joo Lee, Susan K. Seo, Doris M. Ponce, Zainab Shahid, Sergio Giralt, Genovefa A. Papanicolaou, Miguel-Angel Perales, Brian C. Shaffer

Blood Adv (2023) 7 (23): 7153–7160.

https://doi.org/10.1182/bloodadvances.2023010966

Published: 2023

Includes: Supplemental data

Journal Articles

Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults

Blood Adv bloodadvances.2023011862.

https://doi.org/10.1182/bloodadvances.2023011862

Published: 2023

Includes: Supplemental data

Journal Articles

Gender disparities in allograft access due to HLA-sensitization in multiparous women

Warren B Fingrut, Eric Davis, Anne Archer, Samantha Brown, Sean M. Devlin, Stephanie Chinapen, Andromachi Scaradavou, Ioannis Politikos, Amanda Blouin, Brian C Shaffer, Juliet Barker

Blood Adv bloodadvances.2023011893.

https://doi.org/10.1182/bloodadvances.2023011893

Published: 2023

Journal Articles

Comparing Super-Utilizers and Lower-Utilizers Among Commercial- and Medicare-Insured Adults with Sickle Cell Disease

Sarah R. MacEwan, Chienwei Chiang, Sarah H. O'Brien, Susan E Creary, Chyongchiou J Lin, J Madison Hyer, Robert M Cronin

Blood Adv bloodadvances.2023010813.

https://doi.org/10.1182/bloodadvances.2023010813

Published: 2023

Includes: Supplemental data

Journal Articles

International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27

Blood Adv (2023) 7 (22): 7045–7055.

https://doi.org/10.1182/bloodadvances.2023010841

Published: 2023

Includes: Supplemental data

Journal Articles

Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm: a 2-speed cure in the United States and European Union

Caterina Giovanna Valentini, Livio Pagano

Blood Adv (2023) 7 (22): 7084–7086.

https://doi.org/10.1182/bloodadvances.2023011586

Published: 2023

Journal Articles

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

Emily C. Liang, Aya Albittar, Jennifer J. Huang, Alexandre V. Hirayama, Erik L. Kimble, Andrew J. Portuguese, Aude Chapuis, Mazyar Shadman, Brian G. Till, Ryan D. Cassaday, Filippo Milano, Hans-Peter Kiem, Stanley R. Riddell, Cameron J. Turtle, David G. Maloney, Jordan Gauthier

Blood Adv (2023) 7 (22): 6990–7005.

https://doi.org/10.1182/bloodadvances.2023011399

Published: 2023

Includes: Supplemental data

Journal Articles

Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis

Diego Adrianzen-Herrera, Andrew D. Sparks, Rohit Singh, David Alejos-Castillo, Akshee Batra, Shira Glushakow-Smith, Kith Pradhan, Aditi Shastri, Neil A. Zakai

Blood Adv (2023) 7 (22): 6913–6922.

https://doi.org/10.1182/bloodadvances.2023011050

Published: 2023

Includes: Supplemental data

Journal Articles

Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL

Constantine Tam, Javier Pinilla-Ibarz, Carolina G. Castillo, Ana Cristina Fenili, Kathryn Huntley, Volkan Karakus, Mervat Mattar, Miguel A. Miroli, Catherine Moura, Miguel Pavlovsky, Fernando Piotrowski, Martin Šimkovič, Stephan Stilgenbauer

Blood Adv (2023) 7 (22): 6819–6828.

https://doi.org/10.1182/bloodadvances.2023010879

Published: 2023

Includes: Supplemental data

Journal Articles

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

Kaitlin Annunzio, Natalie S. Grover, Rina Li Welkie, Pallawi Torka, Marcus P. Watkins, Andrea Anampa-Guzmán, Montreh Tavakkoli, Timothy S. Oh, Heather Reves, Daniel Jones, Walter Hanel, Beth Christian, Praveen Ramakrishnan Geethakumari, Reem Karmali, Stefan K. Barta, Nancy L. Bartlett, Adam J. Olszewski, Narendranath Epperla

Blood Adv (2023) 7 (22): 6839–6843.

https://doi.org/10.1182/bloodadvances.2023011288

Published: 2023

Includes: Supplemental data

Journal Articles

World Coalition on SCD launches, sparking global focus on SCD diagnosis and care

Andrew Zapfel, Alexis Thompson, Kenneth Bridges, Juliana Richardson, Lwimba Kasongo, Christophe Przybylski, Charles Kiyaga, Prebo Barango, Isaac Odame

Blood Adv (2023) 7 (22): 6812–6814.

https://doi.org/10.1182/bloodadvances.2023010907

Published: 2023

Journal Articles

Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines

Thomas V. Adamkiewicz, Marianne E. M. Yee, Stepy Thomas, Amy Tunali, Kristina W. Lai, Folashade S. Omole, Peter A. Lane, Inci Yildirim

Blood Adv (2023) 7 (21): 6751–6761.

https://doi.org/10.1182/bloodadvances.2022009643

Published: 2023

Includes: Supplemental data

Journal Articles

Hematology referral madness syndrome

Benjamin Djulbegovic, Charles S. Greenberg

Blood Adv (2023) 7 (21): 6702–6704.

https://doi.org/10.1182/bloodadvances.2023011434

Published: 2023

Journal Articles

Contraception, pregnancy, and STI counseling and care among transitioning young adults with sickle cell disease

Divya Shankar, Charis J. Stanek, Suzy Bangudi, Sophia M. Liles, Zachary A. Colton, Laura C. Hart, Robert M. Cronin, Susan E. Creary, Leena Nahata

Blood Adv (2023) 7 (21): 6668–6671.

https://doi.org/10.1182/bloodadvances.2023011008

Published: 2023

Journal Articles

FUTURES: efficacy and acceptability of a novel reproductive health education program for adolescent males with sickle cell disease

Charis J. Stanek, Susan E. Creary, Sophia M. Liles, Zachary A. Colton, Joseph R. Stanek, Gwendolyn P. Quinn, Toyetta Barnard-Kirk, Mary Ann Abrams, Leena Nahata

Blood Adv (2023) 7 (21): 6648–6651.

https://doi.org/10.1182/bloodadvances.2023011024

Published: 2023

Journal Articles

Disparities in survival of hematologic malignancies in the context of social determinants of health: a systematic review

Marisol Miranda-Galvis, Kellen C. Tjioe, E. Andrew Balas, Gagan Agrawal, Jorge E. Cortes

Blood Adv (2023) 7 (21): 6466–6491.

https://doi.org/10.1182/bloodadvances.2023010690

Published: 2023

Includes: Supplemental data

Journal Articles

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

Herve Ghesquieres, Fanny Cherblanc, Aurelien Belot, Sophie Micon, Krimo Bouabdallah, Cyril Esnault, Luc-Matthieu Fornecker, Katia Thokagevistk, Maxime Bonjour, Fontanet Bijou, Corinne Haioun, Nadine Morineau, Loïc Ysebaert, Gandhi Damaj, Benoit Tessoulin, Stéphanie Guidez, Franck Morschhauser, Catherine Thieblemont, Adrien Chauchet, Remy Gressin, Fabrice Jardin, Christophe Fruchart, Gaelle Labouré, Ludovic Fouillet, Pauline Lionne-Huyghe, Antoine Bonnet, Laure Lebras, Sandy Amorim, Cecile Leyronnas, Gaelle Olivier, Romain Guieze, Roch Houot, Vincent Launay, Bernard Drénou, Olivier Fitoussi, Laurence Detourmignies, Julie Abraham, Carole Soussain, Florence Lachenal, Gian Matteo Pica, Patrick Fogarty, Pascale Cony-Makhoul, Adeline Bernier, Sandra Le Guyader-Peyrou, Alain Monnereau, Frédéric Boissard, Cédric Rossi, Vincent Camus

Blood Adv bloodadvances.2023010798.

https://doi.org/10.1182/bloodadvances.2023010798

Published: 2023

Includes: Supplemental data

Journal Articles

Implementation of Hospital-Based Sickle Cell Newborn Screening and Follow-Up Programs in Haiti

Ofelia A. Alvarez, Nora St Victor Dély, Michele Paul Hanna, Rony Saint Fleur, Sarah Wishnek Metalonis, Tally Hustace, Marie Cetoute, Eric C. Brown, Louis Herns Marcelin, Emanise Muscadin, Mrs, Ronald Eveillard, Md, Emmeline Lerebours

Blood Adv bloodadvances.2023010104.

https://doi.org/10.1182/bloodadvances.2023010104

Published: 2023

Includes: Supplemental data

Journal Articles

Dyadic communication in rare cancer: a registry-based study of patients with Erdheim-Chester disease and their caregivers

Anne S. Reiner, Allison J. Applebaum, Dana Bossert, Justin J. Buthorn, Allison M. Sigler, Deanna Fournier, Kathleen Brewer, Thomas M. Atkinson, Kathleen A. Lynch, Jaime Gilliland, Jun J. Mao, Katherine S. Panageas, Eli L. Diamond

Blood Adv (2023) 7 (19): 5904–5910.

https://doi.org/10.1182/bloodadvances.2023010827

Published: 2023

Journal Articles

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies

Kelly S. Chien, Christine B. Peterson, Elliana Young, Dai Chihara, Elizabet E. Manasanch, Jeremy L. Ramdial, Philip A. Thompson

Blood Adv (2023) 7 (19): 5691–5697.

https://doi.org/10.1182/bloodadvances.2022008827

Published: 2023

NARROW

Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant

Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults

Gender disparities in allograft access due to HLA-sensitization in multiparous women

Comparing Super-Utilizers and Lower-Utilizers Among Commercial- and Medicare-Insured Adults with Sickle Cell Disease

International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27

Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm: a 2-speed cure in the United States and European Union

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis

Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

World Coalition on SCD launches, sparking global focus on SCD diagnosis and care

Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines

Hematology referral madness syndrome

Contraception, pregnancy, and STI counseling and care among transitioning young adults with sickle cell disease

FUTURES: efficacy and acceptability of a novel reproductive health education program for adolescent males with sickle cell disease

Disparities in survival of hematologic malignancies in the context of social determinants of health: a systematic review

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

Implementation of Hospital-Based Sickle Cell Newborn Screening and Follow-Up Programs in Haiti

Dyadic communication in rare cancer: a registry-based study of patients with Erdheim-Chester disease and their caregivers

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only